Forbion, a leading venture capital firm with deep biotech expertise in Europe announces it has led the €18 million Series A financing round through its BioEconomy fund of German tech startup EEDEN ...

Portage Biotech Inc.'s (PRTG) shares soared over 27% on Monday, marking their best session in more than three weeks, after ...

A Bay Area biotech giant is receiving growing attention for its approach to a topic that has been historically stigmatized ...

Photo shows Dr. Ron Cohen, founder, former chairman and CEO of Acorda Therapeutics, speaking at the healthcare symposium ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

New Mexico Venture Studio has goals to identify, support, launch and retain startups in New Mexico, with a focus on ...

Portal is poised to add additional lab space to help address the region's demand for infrastructure and specialized lab ...

Ferrer’s R&D work focuses on neurological and pulmonary diseases, and the Spanish pharma has bought into ALS assets in the ...

Shares of Portage Biotech climbed after the company reported confirmatory data for its PORT-7 treatment of mesothelioma, supporting plans for a human trial. The stock rose 21% to $10.23 Monday. Shares ...

Shares of Biohaven ( BHVN 5.24%) are surging on Monday. The company's stock was up about 8% as of midday trading and had ...

In February, the HHS unexpectedly delivered notice that the South San Francisco-based company was to stop all work on the ...

Sen. Bill Cassidy’s report calls on Congress to improve the transparency of the drug discount program in a move praised by ...